News
News Center
Jiuzhitang Maker Receives ISO Triple-Certification Recognition
2023-02-17
Recently, Jiuzhitang Maker officially received certification from a reputable accreditation body. International certifications under the three ISO systems: ISO 9001, ISO 14001, and ISO 45001. This is a clear recognition of Jiuzhitang Maker's years of dedicated efforts in standardizing, professionalizing, and systematizing quality management, environmental management, and occupational health and safety management in the field of stem-cell drug R&D.
It is widely known that stem cells are among the most complex products in the history of human medical development, and "quality" remains the cornerstone of the stem cell industry—and also the most fundamental challenge hindering the growth of stem-cell-related industries.
Pursuing high quality is the unwavering belief and principle that has been deeply ingrained in the DNA of Jiuzhitang people for over a century. Since its establishment, Jiuzhitang Maker has consistently pursued a high-quality development path for stem-cell-based pharmaceuticals, focusing on areas such as quality research, quality standards, quality assurance, quality system development, and quality oversight. We have established a seasoned professional team of over ten members, dedicated to in-depth research and innovation in the stem cell quality management system. A unique Jiuzhitang Maker stem cell quality management system has been established.
The attainment of these three system certifications clearly demonstrates Jiuzhitang Maker's robust quality management, environmental management, and occupational health and safety management in the field of stem-cell drug R&D. Our capabilities are robust and fully aligned with international standards. Jiuzhitang Maker is equipped to consistently deliver safer, more reliable, and high-quality stem cell CQDMO services to its clients. As of now, Jiuzhitang Maker has established deep partnerships with several renowned Grade-III hospitals across China, jointly advancing the development of multiple stem cell-based drug pipelines in parallel.
Armed with this "golden key" to unlock international markets and the "pass" to the domestic market, Jiuzhitang Maker will continue to rigorously maintain stem cell quality, refine its institutional framework, strengthen project management, and enhance risk control—steadily elevating the company's standardized and professional management practices. Playing a leading role in the stem cell drug R&D field by "setting standards, establishing rules, and setting benchmarks," Contributing positively to China's stem cell drug research and development field.
Related News
Here is the title—h1 placeholder text
Copyright © Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Powered by: 300.cn SEO | Privacy Policy